(Q38414364)

2 September 2017

1 reference

title

Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy (English)

1 reference

2 September 2017

anti-retroviral agent

0 references

cerebrospinal fluid

0 references

author name string

Francesca Ferretti

1

1 reference

2 September 2017

Magnus Gisslen

2

1 reference

2 September 2017

Paola Cinque

3

1 reference

2 September 2017

Richard W Price

4

1 reference

2 September 2017

1 June 2015

1 reference

2 September 2017

Current HIV/AIDS reports

1 reference

2 September 2017

12

1 reference

2 September 2017

2

1 reference

2 September 2017

280-288

1 reference

https://scigraph.springernature.com/pub.10.1007/s11904-015-0267-7

2 September 2017

0 references

cites work

Central nervous system viral invasion and inflammation during acute HIV infection

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Concentrations of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid after antiretroviral treatment initiated during primary HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

The prevalence and incidence of neurocognitive impairment in the HAART era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Evolving clinical phenotypes in HIV-associated neurocognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Antiretroviral therapy and central nervous system HIV type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

HIV migration between blood and cerebrospinal fluid or semen over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Dual R3R5 tropism characterizes cerebrospinal fluid HIV-1 isolates from individuals with high cerebrospinal fluid viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Transendothelial migration of monocytes: the underlying molecular mechanisms and consequences of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

The HIV-1 env protein: a coat of many colors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Quantification of entry phenotypes of macrophage-tropic HIV-1 across a wide range of CD4 densities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

HIV-1 pathogenesis: the virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Acute meningoencephalitis due to human immunodeficiency virus type 1 infection in 13 patients: clinical description and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Presence of HIV-1 R5 viruses in cerebrospinal fluid even in patients harboring R5X4/X4 viruses in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

HIV coreceptor tropism in paired plasma, peripheral blood mononuclear cell, and cerebrospinal fluid isolates from antiretroviral-naïve subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Two phases of HIV RNA decay in CSF during initial days of multidrug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Where does HIV hide? A focus on the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Determinants of darunavir cerebrospinal fluid concentrations: impact of once-daily dosing and pharmacogenetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

ING116070: a study of the pharmacokinetics and antiviral activity of dolutegravir in cerebrospinal fluid in HIV-1-infected, antiretroviral therapy-naive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Short communication: focal encephalitis related to viral escape and resistance emergence in cerebrospinal fluid in a patient on lopinavir/ritonavir monotherapy with plasma HIV-1 RNA suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

A case of cerebrospinal fluid viral escape on a dual antiretroviral regimen: worth the risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

The role of compartment penetration in PI-Monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Virological efficacy in cerebrospinal fluid and neurocognitive status in patients with long-term monotherapy based on lopinavir/ritonavir: an exploratory study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

A comparative study of neurocognitively impaired patients receiving protease inhibitor monotherapy or triple-drug antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Central nervous system HIV infection in "less-drug regimen" antiretroviral therapy simplification strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Reversible dementia in a patient with central nervous system escape of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

CSF viral escape in a patient with HIV-associated neurocognitive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Therapy failure following selection of enfuvirtide-resistant HIV-1 in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Acute Meningoencephalitis in Chronic Human Immunodeficiency Virus (HIV) Infection: Putative Central Nervous System Escape of HIV Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Neuroimaging in human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Aseptic meningitis and acute HIV syndrome after interruption of antiretroviral therapy: implications for structured treatment interruptions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Encephalitis with infiltration by CD8+ lymphocytes in HIV patients receiving combination antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

CD8 encephalitis in HIV-infected patients receiving cART: a treatable entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Cerebrospinal fluid human immunodeficiency virus viral load in patients with neurosyphilis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Varicella-zoster virus meningitis and cerebrospinal fluid HIV RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Cerebrospinal fluid HIV-1 compartmentalization in a patient with AIDS and acute varicella-zoster virus meningomyeloradiculitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

Lyme neuroborreliosis in HIV-1 positive men successfully treated with oral doxycycline: a case series and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0267-7

HIV type 1 viral encephalitis after development of viral resistance to plasma suppressive antiretroviral therapy

21 January 2018

1 reference

12 December 2020

Central nervous system HIV replication and HIV-related pachymeningitis in a patient on protease inhibitor monotherapy despite an undetectable plasma viral load

1 reference

12 December 2020

Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136.

1 reference

12 December 2020

Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates.

1 reference

12 December 2020

Cerebrospinal fluid viral loads reach less than 2 copies/ml in HIV-1-infected patients with effective antiretroviral therapy

1 reference

12 December 2020

Ongoing HIV replication in cerebrospinal fluid under successful monotherapy

1 reference

12 December 2020

Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir

1 reference

12 December 2020

Quantifying HIV-1 RNA Using the Polymerase Chain Reaction on Cerebrospinal Fluid and Serum of Seropositive Individuals With and Without Neurologic Abnormalities

1 reference

12 December 2020

Differential genotypic evolution of HIV-1 quasispecies in cerebrospinal fluid and plasma: a systematic review.

1 reference

12 December 2020

Highly active antiretroviral therapy improves neurocognitive functioning

1 reference

12 December 2020

Neurologic complications of HIV disease and their treatment

1 reference

12 December 2020

Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain

1 reference

12 December 2020

Human immunodeficiency virus type 1 is present in the cerebrospinal fluid of a majority of infected individuals

1 reference

12 December 2020

Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection

1 reference

12 December 2020

10.1007/S11904-015-0267-7

Identifiers

DOI

1 reference

2 September 2017

1 reference